Factors associated with the receipt of systemic treatment (tx) for metastatic urothelial carcinoma (mUC) in England

Sep 9, 2022 | Publications, Published 2022

Home » Publications » Factors associated with the receipt of systemic treatment (tx) for metastatic urothelial carcinoma (mUC) in England

Kearney M, Knott CS, Mahmoudpour H, Verpillat P. Factors associated with the receipt of systemic treatment (tx) for metastatic urothelial carcinoma (mUC) in England. ESMO 2022; 2022 Sept 9-13

Tags: Craig Knott | Real World Standing Cohorts